Development of bestatin-based activity-based probes for metallo-aminopeptidases.
暂无分享,去创建一个
[1] S. Dalal,et al. Roles for Two Aminopeptidases in Vacuolar Hemoglobin Catabolism in Plasmodium falciparum* , 2007, Journal of Biological Chemistry.
[2] R. Danziger. Aminopeptidase N in arterial hypertension , 2007, Heart Failure Reviews.
[3] Wenfang Xu,et al. The structure and main functions of aminopeptidase N. , 2007, Current medicinal chemistry.
[4] W. Dai,et al. Polo-like Kinases Inhibited by Wortmannin , 2007, Journal of Biological Chemistry.
[5] B. Matthews,et al. Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active site , 2006, Proceedings of the National Academy of Sciences.
[6] W. Dehaen,et al. The application of "click chemistry" for the decoration of 2(1H)-pyrazinone scaffold: generation of templates. , 2005, Journal of combinatorial chemistry.
[7] Carolyn R Bertozzi,et al. A strategy for functional proteomic analysis of glycosidase activity from cell lysates. , 2004, Angewandte Chemie.
[8] Nasreen S Jessani,et al. Activity-based probes for the proteomic profiling of metalloproteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] Yasufumi Sato. Role of aminopeptidase in angiogenesis. , 2004, Biological & pharmaceutical bulletin.
[10] Yasufumi Sato. Aminopeptidases and angiogenesis. , 2003, Endothelium : journal of endothelial cell research.
[11] T. Penning. Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents. , 2001, Current pharmaceutical design.
[12] B. Cravatt,et al. Profiling the specific reactivity of the proteome with non-directed activity-based probes. , 2001, Chemistry & biology.
[13] A. Burlingame,et al. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. , 2000, Chemistry & biology.
[14] T. Foulon,et al. Aminopeptidase B (EC 3.4.11.6). , 1999, The international journal of biochemistry & cell biology.
[15] F. Abe,et al. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines , 1999, Leukemia.
[16] R. Huisgen,et al. 1,3-Dipolar Activity in Cycloadditions of an Aliphatic Sulfine(,)(1). , 1996, The Journal of organic chemistry.
[17] K. Dobashi,et al. Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines. , 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[18] M. Furuno,et al. Crystallization and preliminary X-ray crystallographic studies of recombinant human leukotriene A4 hydrolase complexed with bestatin. , 1994, Journal of molecular biology.
[19] W. Lipscomb,et al. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[20] P. Bartlett,et al. Phosphorus amino acid analogues as inhibitors of leucine aminopeptidase. , 1987, Journal of medicinal chemistry.
[21] J. M. Prescott,et al. The slow, tight binding of bestatin and amastatin to aminopeptidases. , 1985, The Journal of biological chemistry.
[22] D. Rich,et al. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes. , 1984, Journal of medicinal chemistry.
[23] P. Dennis,et al. Inhibition of leucine aminopeptidase by amino acid hydroxamates. , 1982, The Journal of biological chemistry.
[24] T. Aoyagi,et al. Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomer. , 1976, Archives of biochemistry and biophysics.